Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
about
Ethnopharmacological survey of medicinal plants used by traditional healers and indigenous people in chittagong hill tracts, bangladesh, for the treatment of snakebite.Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectivesInteraction of sanguinarine alkaloid, isolated from argemone oil, with hepatic cytochrome p450 in rats.Quaternary alkaloids of Argemone mexicana.Dropsy outbreak in a single family in Punjab, IndiaPhenotype of hepatic xenobiotic metabolizing enzymes and CYP450 isoforms of sanguinarine treated rats: effect of P450 inducers on its toxicity.Cytotoxicity of alkaloids isolated from Argemone mexicana on SW480 human colon cancer cell line.The cause of endomyocardial fibrosis in Uganda.Biophysical aspects and biological implications of the interaction of benzophenanthridine alkaloids with DNA.Argemone oil induces genotoxicity in mice.Protective Effect of Solanum nigrum Leaves Extract on Immobilization Stress Induced Changes in Rat's Brain.Epidemic dropsy 2013: case series.Protective effect of topical application of α-tocopherol and/or N-acetyl cysteine on argemone oil/alkaloid-induced skin tumorigenesis in mice.Visual field defects in epidemic dropsy.Role of ErbB2 mediated AKT and MAPK pathway in gall bladder cell proliferation induced by argemone oil and butter yellow. Argemone oil and butter yellow induced gall bladder cell proliferation.Role of quercetin on PCBs (Aroclor-1254) induced impairment of dopaminergic receptor mRNA expression in cerebral cortex of adult male rats.
P2860
Q21284486-7C7860C2-518B-427B-BC7D-ADD388388B71Q26769949-DD4FA957-4881-4EB9-9BBB-C372BDD9B4A6Q34088907-9D0F8C6F-55D8-4844-AD39-B4E10F044B41Q34127058-64660384-4F23-407E-9C09-849C7A39F1CAQ34281624-2350C16B-CAC0-4A23-8C60-2A51AA194D6DQ35005591-A45A9E54-4DC9-460D-BC7F-A8BEDA741EF2Q38830092-0CCB6979-040C-48E3-AD3C-DBE05C68E53CQ38867458-76EFAE60-BCB7-44F6-AA21-2C19A55D69F0Q39310190-16694533-8EC9-435E-A7C5-917CDD89300BQ40983271-D3F3B4A2-6884-4149-9B53-BCBF2D47B642Q41977287-261E55E5-7E6D-4244-B816-A395373459FFQ42176217-0BED485A-CE90-4D63-94BD-CED1E716E935Q42261930-E43A7712-9005-48F4-B8A1-0E48204F8932Q44205112-80EDF58B-426B-4A33-8208-83526178A401Q51804426-82ABE7DC-EF6A-4267-9C37-F3225E22C880Q54598159-0E626A1F-D7BD-467F-8BC4-4EDADD4CB023
P2860
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@ast
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@en
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@nl
type
label
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@ast
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@en
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@nl
prefLabel
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@ast
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@en
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@nl
P2860
P1476
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil
@en
P2093
P2860
P304
P356
10.3109/10408449709089896
P407
P577
1997-05-01T00:00:00Z